Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP233207.RAnqUXKJqjfnp_1TD_q5HcuaJ2dB78T1wezEHU9VFoGNE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP233207.RAnqUXKJqjfnp_1TD_q5HcuaJ2dB78T1wezEHU9VFoGNE130_assertion type Assertion NP233207.RAnqUXKJqjfnp_1TD_q5HcuaJ2dB78T1wezEHU9VFoGNE130_head.
- NP233207.RAnqUXKJqjfnp_1TD_q5HcuaJ2dB78T1wezEHU9VFoGNE130_assertion description "[BRCA1 (71.0%), WT1 (38.7%), and RARB (38.7%) were the most frequently methylated genes in bladder tumors, with WT1 methylation being significantly associated with tumor stage (P = 0.011).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233207.RAnqUXKJqjfnp_1TD_q5HcuaJ2dB78T1wezEHU9VFoGNE130_provenance.
- NP233207.RAnqUXKJqjfnp_1TD_q5HcuaJ2dB78T1wezEHU9VFoGNE130_assertion evidence source_evidence_literature NP233207.RAnqUXKJqjfnp_1TD_q5HcuaJ2dB78T1wezEHU9VFoGNE130_provenance.
- NP233207.RAnqUXKJqjfnp_1TD_q5HcuaJ2dB78T1wezEHU9VFoGNE130_assertion SIO_000772 21227392 NP233207.RAnqUXKJqjfnp_1TD_q5HcuaJ2dB78T1wezEHU9VFoGNE130_provenance.
- NP233207.RAnqUXKJqjfnp_1TD_q5HcuaJ2dB78T1wezEHU9VFoGNE130_assertion wasDerivedFrom befree-20140225 NP233207.RAnqUXKJqjfnp_1TD_q5HcuaJ2dB78T1wezEHU9VFoGNE130_provenance.
- NP233207.RAnqUXKJqjfnp_1TD_q5HcuaJ2dB78T1wezEHU9VFoGNE130_assertion wasGeneratedBy ECO_0000203 NP233207.RAnqUXKJqjfnp_1TD_q5HcuaJ2dB78T1wezEHU9VFoGNE130_provenance.